2,2-dibromo-3-nitrilopropionamide has been researched along with Erythema Multiforme in 1 studies
*Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, K; Iwatsuki, K; Nakayama, Y; Senoh, A; Tokuyama, Y | 1 |
1 other study(ies) available for 2,2-dibromo-3-nitrilopropionamide and Erythema Multiforme
| Article | Year |
|---|---|
Erythema multiforme-like contact reaction due to liquid-formulated 2,2-dibromo-3-nitrilopropionamide: involvement of cytotoxic T-lymphocyte reaction.
Topics: Adult; CD8-Positive T-Lymphocytes; Cytotoxicity, Immunologic; Erythema Multiforme; Humans; Lymphocyte Activation; Male; Nitriles; Organophosphorus Compounds; T-Lymphocytes, Cytotoxic | 2009 |